Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel S Key

Showing results (181-190 of 255) with videos related to

Pageof 26
Sort By:
Diabetes Care|September 2, 2015
Sickle Cell Trait Worsens Oxidative Stress, Abnormal Blood Rheology, and Vascular Dysfunction in Type 2 DiabetesMor Diaw, Vincent Pialoux, Cyril Martin, et al.
Blood Advances|November 8, 2019
Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia BAnnette Von Drygalski, Adam Giermasz, Giancarlo Castaman, et al.
Research and Practice in Thrombosis and Haemostasis|April 26, 2024
Fewer severe infections with tranexamic acid in patients with hematologic malignanciesJacqueline N Poston, Siobhan P Brown, Anton Ilich, et al.
Blood Advances|April 9, 2024
Plasma kallikrein supports FXII-independent thrombin generation in mouse whole bloodJun Wan, Sophia Dhrolia, Rohan R Kasthuri, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 18, 2021
Pharmacokinetics of perioperative FVIII in adult patients with haemophilia A: An external validation and development of an alternative population pharmacokinetic modelJing Zhu, Yi Shuan Wu, Ryan J Beechinor, et al.
Blood|December 4, 2004
Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon systemJohn R Ohlfest, Joel L Frandsen, Sabine Fritz, et al.
Blood|January 24, 2020
Red blood cell microvesicles activate the contact system, leading to factor IX activation via 2 independent pathwaysDenis F Noubouossie, Michael W Henderson, Micah Mooberry, et al.
Blood Transfusion = Trasfusione Del Sangue|February 14, 2025
The impact of red cell storage age on transfused patients with sickle cell disease: protocol of a pilot randomized clinical trial to evaluate changes in inflammation and clinical transfusion efficacyMatthew S Karafin, Ross M Fasano, Anton Illich, et al.
Blood Advances|March 14, 2025
Addressing the pathophysiology of venous thrombosis and chronic kidney disease in sickle cell trait using a mouse modelFatima Trebak, Mohammad O Sako, Steven P Grover, et al.
American Journal of Hematology|July 18, 2009
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: TreatmentWalter Ageno, David Garcia, Maria I Aguilar, et al.
Pageof 26

Showing results (181-190 of 255) with videos related to

Sort By:
Pageof 26
Diabetes Care|September 2, 2015
Sickle Cell Trait Worsens Oxidative Stress, Abnormal Blood Rheology, and Vascular Dysfunction in Type 2 DiabetesMor Diaw, Vincent Pialoux, Cyril Martin, et al.
Blood Advances|November 8, 2019
Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia BAnnette Von Drygalski, Adam Giermasz, Giancarlo Castaman, et al.
Research and Practice in Thrombosis and Haemostasis|April 26, 2024
Fewer severe infections with tranexamic acid in patients with hematologic malignanciesJacqueline N Poston, Siobhan P Brown, Anton Ilich, et al.
Blood Advances|April 9, 2024
Plasma kallikrein supports FXII-independent thrombin generation in mouse whole bloodJun Wan, Sophia Dhrolia, Rohan R Kasthuri, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 18, 2021
Pharmacokinetics of perioperative FVIII in adult patients with haemophilia A: An external validation and development of an alternative population pharmacokinetic modelJing Zhu, Yi Shuan Wu, Ryan J Beechinor, et al.
Blood|December 4, 2004
Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon systemJohn R Ohlfest, Joel L Frandsen, Sabine Fritz, et al.
Blood|January 24, 2020
Red blood cell microvesicles activate the contact system, leading to factor IX activation via 2 independent pathwaysDenis F Noubouossie, Michael W Henderson, Micah Mooberry, et al.
Blood Transfusion = Trasfusione Del Sangue|February 14, 2025
The impact of red cell storage age on transfused patients with sickle cell disease: protocol of a pilot randomized clinical trial to evaluate changes in inflammation and clinical transfusion efficacyMatthew S Karafin, Ross M Fasano, Anton Illich, et al.
Blood Advances|March 14, 2025
Addressing the pathophysiology of venous thrombosis and chronic kidney disease in sickle cell trait using a mouse modelFatima Trebak, Mohammad O Sako, Steven P Grover, et al.
American Journal of Hematology|July 18, 2009
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: TreatmentWalter Ageno, David Garcia, Maria I Aguilar, et al.
Pageof 26